The authors reply

New England Journal of Medicine

Volumn 371, Issue 12, 2014, Pages 1168-1169

  Huybrechts, Krista F ^a   Hernández Díaz, Sonia ^b   Avorn, Jerry ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

CONGENITAL HEART MALFORMATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG EXPOSURE; DRUG USE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; LETTER; PRENATAL DIAGNOSIS; PRESCRIPTION; PUBLICATION; PUERPERAL DEPRESSION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TERATOGENICITY; THERAPEUTIC ABORTION; TREATMENT PLANNING; CHEMICALLY INDUCED DISORDER; DEPRESSION; FEMALE; MALE; NOTE; PREGNANCY; PREGNANCY COMPLICATION;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84907404347     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1409203     Document Type: Letter

References (5)

1. Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernández-Díaz S. Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf 2014; 23:646-55.
2. Toh S, Mitchell AA, Werler MM, Hernández-Díaz S. Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception. Am J Epidemiol 2008;167:633-40.
3. Cooper WO, Willy ME, Pont SJ, Ray WA. Increasing use of antidepressants in pregnancy. Am J Obstet Gynecol 2007; 196(6):544.e1-545.e1.
4. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernandez-Diaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008. Am J Obstet Gynecol 2011;205(1):51.e1-58.e1.
5. Huybrechts KF, Palmsten K, Mogun H, et al. National trends in antidepressant medication treatment among publicly insured pregnant women. Gen Hosp Psychiatry 2013;35:265-71.